Adaptive designs: Looking for a needle in the haystack - A new challenge in medical research

Statistics in Medicine

Volumn 27, Issue 10, 2008, Pages 1565-1580

  Bauer, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adaptive designs; False discovery rate; Feasibility; Large number of hypotheses; Optimality; Pilot designs; Prediction scores; Weighting

Indexed keywords

ARTICLE; HYPOTHESIS; MEDICAL RESEARCH; METHODOLOGY; PILOT STUDY; PREDICTION; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING; SIMULATION; STATISTICAL ANALYSIS;

BIOMEDICAL RESEARCH; BIOMETRY; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; RESEARCH DESIGN; ROC CURVE;

EID: 42449103475     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3090     Document Type: Article

References (41)

1. Flurnoy N, Rosenberger WF (eds). Special issue on adaptive designs in clinical trials. Journal of Statistical Planning and Inference 2006; 136:1747-1955.
2. Brunner E, Schuhmacher M (eds). Adaptive designs in clinical trials. Biometrical Journal 2006; 48:491-737.
3. Burman CF, Sonesson C. Are flexible designs sound? Biometrics 2006; 62:664-669; 681-684.
4. Proschan MA. Discussion of the paper: Burman CF, Sonesson C. Are flexible designs sound. Biometrics 2006; 62:674-676.
5. Bauer P. Multistage testing with adaptive designs; with discussion. Biometrie und Informatik in Medizin und Biologie 1989; 20:130-148.
6. Bauer P, Köhne K. Evaluatiqn of experiments with adaptive interim analyses. Biometrics 1994; 50:1029-1041.
7. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics 1999; 55:1286-1290.
8. Cui L, Hung HMJ, Wang S. Modification of sample size in group sequential trials. Biometrics 1999; 55:321-324.
9. Hedges LV, Olkin I. Statistical Methods of Meta-analysis. Academic Press: New York, London, 1985.
10. Liu Q, Proschan MA, Pledger GW. A unified theory of two-stage adaptive designs. Journal of the American Statistical Association 2002; 97:1034-1041.
11. Brannath W, Posch M, Bauer P. Recursive combination tests. Journal of the American Statistical Association 2002; 97:236-244.
12. Bauer P, Kieser M. Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 1999; 18:1833-1848.
13. Kieser M, Bauer P, Lehmacher W. Inference on multiple endpoints in clinical trials with adaptive interim analyses. Biometrical Journal 1999; 41:261-277.
14. Hommel G. Adaptive modifications of hypotheses after an interim analysis. Biometrical Journal 2001; 43:581-589.
15. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51:1315-1324.
16. Müller H-H, Schäfer H. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches. Biometrics 2001; 57:886-891.
17. Müller H-H, Schäfer H. A general statistical principle for changing a design any time during the course of a trial. Statistics in Medicine 2004; 23:2497-2508.
18. Posch M, Timmesfeld N, König F, Müller H-H. Conditional rejection probabilities of Student's t-test, (non)-stochastic curtailment, and design adaptations. Biometrical Journal 2004; 46:389-403.
19. Posch M, Bauer P. Adaptive two stage designs and the conditional error function. Biometrical Journal 1999; 41:689-696.
20. Tsiatis AA, Metha C. On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika 2003; 90:367-378.
21. Jennison C, Turnbull BW. Adaptive and nonadaptive group sequential tests. Biometrika 2006; 93:1-21.
22. Brannath W, Bauer P, Posch M. On the efficiency of adaptive designs for flexible interim decisions in clinical trials. Journal of Statistical Planning and Inference 2006; 136:1956-1961.
23. Jennison C, Turnbull BW. Mid-course sample size modification in clinical trials based on the observed treatment effect. Statistics in Medicine 2003; 22:971-993.
24. Bauer P, König F. The reassessment of trial perspectives from interim data - a critical view. Statistics in Medicine 2006; 25:23-36.
25. Posch M, Bauer P, Brannath W. Issues in designing flexible trials. Statistics in Medicine 2003; 22:953-969.
26. Denne JS. Sample size recalculation using conditional power. Statistics in Medicine 2001; 20:2645-2660.
27. Wassmer G. Statistische Testverfahren für gruppensequentielle und adaptive Pläne in klinischen Studien. Verlag Alexander Mönch: Köln, 1999.
28. Brannath W, Koenig F, Bauer P. Estimation in flexible two stage designs. Statistics in Medicine 2006; 25: 3366-3381.
29. Posch M, Koenig F, Branson M, Brannath W, Dunger-Baldauf C, Bauer P. Testing and estimation in flexible group sequential designs with adaptive treatment selection. Statistics in Medicine 2005; 30:3697-3714.
30. Mehta CR, Bauer P, Posch M, Brannath W. Repeated confidence intervals for adaptive group sequential trials. 2007, to appear.
31. Bauer P, Einfalt J. Application of adaptive designs - a review. Biometrical Journal 2006; 48:493-506.
32. + exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction - results of the evaluation of the safety and cardioprotective effects ofeniporide in acute myocardial infarction (ESCAMI) trial. Journal of the American College of Cardiology 2001; 38:1644-1650.
33. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 1995; 57:289-300.
34. Storey JD. A direct approach to false discovery rate. Journal of the Royal Statistical Society, Series B 2002; 64:479-498.
35. Storey JD, Taylor JE, Siegmund D. Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. Journal of the Royal Statistical Society, Series B 2004; 66:187-205.
36. Zehetmayer S, Bauer P, Posch M. Two-stage designs for experiments with a large number of hypotheses. Bioinformatics 2005; 21:3771-3777.
37. Zehetmayer S, Bauer P, Posch M. Optimized multi-stage designs for a large number of hypotheses. 2007, submitted.
38. Goll A, Bauer P. Two-stage designs applying methods differing in costs. Bioinformatics 2007; 23:1519-1526.
39. Futschik A, Posch M. On the optimum number of hypotheses to test when the number of observations is limited. Statistica Sinica 2005; 15:841-855.
40. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation study. The Lancet 2005; 365:488-492.
41. Ntzani EE, Ioannidis JPA. Predictive ability of DNA microarrys for cancer outcomes and correlates: an empirical assessment. The Lancet 2003; 362:1439-1444.